TRASTUZUMAB IN METASTATIC BREAST CANCER: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES

被引：0
|
作者：
Andrade, T. S. D. [1 ]
Mosegui, G. B. G. [1 ]
Miranda, E. S. [1 ]
Souza, T. F. G. D. [1 ]
Vianna, C. M. D. M. [2 ]
Silva, F. V. C. [3 ]
机构：
[1] Univ Fed Fluminense, Niteroi, RJ, Brazil
[2] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil
[3] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2044
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A687 / A687
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal
    Wang, Shi-Yi
    Dang, Weixiong
    Richman, Ilana
    Mougalian, Sarah S.
    Evans, Suzanne B.
    Gross, Cary P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (16) : 1619 - +
  • [22] Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer
    Yubo Wang
    Sean P. Gavan
    Douglas Steinke
    Kwok-Leung Cheung
    Li-Chia Chen
    Cost Effectiveness and Resource Allocation, 20
  • [23] Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil
    Botelho, Carlos Henrique
    Estevez-Diz, Maria Del Pilar
    Campolina, Alessandro Goncalves
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (01) : 63 - 72
  • [24] BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER: A LITERATURE REVIEW ON META-ANALYSES AND COST-EFFECTIVENESS ANALYSES
    Sun, Y.
    Liu, G.
    VALUE IN HEALTH, 2014, 17 (07) : A733 - A733
  • [25] REVIEW OF COST EFFECTIVENESS OF TRASTUZUMAB IN EARLY BREAST CANCER
    Van Rooijen, E. M.
    Krol, M.
    VALUE IN HEALTH, 2011, 14 (07) : A470 - A470
  • [26] Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
    Zhang, Wei
    Islam, Nazrul
    Ma, Canice
    Anis, Aslam H.
    PHARMACOECONOMICS, 2015, 33 (04) : 327 - 340
  • [27] A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
    Phillips, KA
    Van Bebber, SL
    PHARMACOGENOMICS, 2004, 5 (08) : 1139 - 1149
  • [28] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Wan, Y.
    Zeng, F.
    Tan, H.
    Lu, Y.
    Zhang, Y.
    Zhao, L.
    You, R.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 979 - 1015
  • [29] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Y. Wan
    F. Zeng
    H. Tan
    Y. Lu
    Y. Zhang
    L. Zhao
    R. You
    Osteoporosis International, 2022, 33 : 979 - 1015
  • [30] Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
    Wei Zhang
    Nazrul Islam
    Canice Ma
    Aslam H. Anis
    PharmacoEconomics, 2015, 33 : 327 - 340
12345